Thomas Göhler

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

Gastrointestinal Oncology, Medicine, Pathology +8

Sorafenib in Patients with Hepatocellular Carcinoma—Results of the Observational INSIGHT Study

Tom M. Ganten, Rudolf Stauber, E. Schott et al. · Clinical Cancer Research · 2017 · 92 citations

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

Nadia Harbeck, Peter A. Fasching, Rachel Wuerstlein et al. · Annals of Oncology · 2023 · 39 citations · Full text

Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany

Peter Dall, G Lenzen, Thomas Göhler et al. · Journal of Geriatric Oncology · 2015 · 34 citations

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

Thomas Decker, Friedrich Overkamp, Siegfried Rösel et al. · BMC Cancer · 2017 · 26 citations · Full text